Jennifer B. Green

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Clinical Research Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD”.

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

Journal of the American Society of Nephrology(2023)10.1681/asn.0000000000000271

N/A

1.4DataRank · unranked

45 citations

Natalie Staplin, David Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka +25 more

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

Circulation(2024)10.1161/circulationaha.123.066604

N/A

0.773DataRank · unranked

24 citations

Brendan M. Everett, Alokananda Ghosh, Naji Younes, Heidi Krause‐Steinrauf, Joshua I. Barzilay +95 more

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022

N/A

0.532DataRank · unranked

22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Association of Glycemia, Lipids, and Blood Pressure With Cognitive Performance in People With Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Care(2021)10.2337/dc20-2858

N/A

0.426DataRank · unranked

9 citations

Naji Younes, Jennifer J. Manly, Joshua I. Barzilay, Willy Marcos Valencia, Mary Larkin +94 more

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf160

N/A

0.253DataRank · unranked

4 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Sung Gyun Kim, Johannes F.E. Mann, Janet B. McGill +10 more

Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

Nephrology Dialysis Transplantation(2022)10.1093/ndt/gfac198

N/A

0DataRank · unranked

160 citations

Amy K. Mottl, George L. Bakris, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill +6 more

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.48030

N/A

0DataRank · unranked

74 citations

Emily C. O’Brien, Lisa A. Kaltenbach, Jennifer B. Green, Renato D. Lópes, Caryn G. Morse +16 more

Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes

JACC Heart Failure(2021)10.1016/j.jchf.2021.11.001

N/A

0DataRank · unranked

33 citations

Nicole Solomon, Adam D. DeVore, Abhinav Sharma, G. Michael Felker, Adrian F. Hernandez +9 more

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes

JCI Insight(2023)10.1172/jci.insight.168563

N/A

0DataRank · unranked

14 citations

Robert J. Mentz, Maggie Nguyen, Jennifer B. Green, L. Truby, Olga Ilkayeva +15 more

The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus

Journal of Diabetes Science and Technology(2023)10.1177/19322968231204584

N/A

0DataRank · unranked

11 citations

Tadej Battelino, Richard M. Bergenstal, Thomas Först, Jennifer B. Green, Chantal Mathieu +4 more

Pancreatic Safety of Sitagliptin in the TECOS Study

UNC Libraries(2020)10.17615/7280-h844

N/A

0DataRank · unranked

0 citations

Yuliya Lokhnygina, Tsvetalina Tankova, Jennifer B. Green, Pablo Aschner, Keyur P. Patel +10 more

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae006

N/A

0DataRank · unranked

15 citations

Guillaume Marquis‐Gravel, Shannon Murphy, Karen P. Alexander, Karen Chiswell, Jennifer B. Green +8 more

Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort

Diabetes Research and Clinical Practice(2020)10.1016/j.diabres.2020.108235

N/A

0DataRank · unranked

32 citations

Ionut Bebu, Chelsea Baker, Robert M. Cohen, Jill P. Crandall, Cyrus Desouza +11 more

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

Circulation(2020)10.1161/circulationaha.119.041022

N/A

0DataRank · unranked

109 citations

Neha J. Pagidipati, Robert M. Califf, Darren K. McGuire, Jennifer B. Green, Dave DeMets +16 more